Multi-view deep learning framework for the detection of chest X-rays compatible with pediatric pulmonary tuberculosis
Tuberculosis (TB) remains a major global health burden, particularly in low-resource, high-prevalence regions. Pediatric TB diagnosis poses challenges with non-specific symptoms and less distinct radiological manifestations than adult TB. Many affected children remain undiagnosed or untreated. The World Health Organization (WHO) recommends chest X-ray (CXR) for TB screening and triage, given its accessibility and rapid assessment of pulmonary TB-related abnormalities. We present pTBLightNet, a multi-view deep learning framework to detect pediatric pulmonary TB by identifying TB-compatible CXRs with consistent radiological findings. Leveraging both frontal and lateral CXR views, our framework is pre-trained on adult CXR datasets (N = 114,173), then fine-tuned or trained from scratch, and subsequently evaluated on CXR datasets (N = 918) from three pediatric TB cohorts. It achieves an area under the curve (AUC) of 0.903 and 0.682 on internal and external testing, respectively. External evaluation supports its effectiveness and generalizability using CXR TB compatibility, expert reading, microbiological confirmation and case definition as reference standards. Age-specific models (<5 and 5-18 years) perform competitively with those trained on larger undifferentiated populations, and adding lateral CXRs improves diagnosis in younger children. These results highlight the robustness of our approach across age groups and its potential to improve TB diagnosis, particularly in resource-limited settings.
Authors
- Orvalho Augusto (ORCID: https://orcid.org/0000-0002-0005-3968)
- Hendrik Simon Schaaf (ORCID: https://orcid.org/0000-0001-5755-4133)
- Pooneh Roshanitabrizi (ORCID: https://orcid.org/0000-0002-8853-2786)
- María J. Ledesma‐Carbayo (ORCID: https://orcid.org/0000-0001-6846-3923)
- Daniel Capellán-Martín (ORCID: https://orcid.org/0000-0002-9743-0845)
- Begoña Santiago (ORCID: https://orcid.org/0000-0002-4125-0423)
- Elisa López‐Varela (ORCID: https://orcid.org/0000-0002-6725-5687)
- Daniel Blázquez‐Gamero (ORCID: https://orcid.org/0000-0001-6483-8329)
- Ramon Sanchez (ORCID: https://orcid.org/0000-0003-0100-3230)
- Jose Luis Ribó
- Juan J. Gómez-Valverde (ORCID: https://orcid.org/0000-0002-5073-5908)
- Ángel Lancharro (ORCID: https://orcid.org/0000-0001-9439-1951)
- Alberto L. García‐Basteiro (ORCID: https://orcid.org/0000-0002-2038-5505)
- Antoni Noguera‐Julián (ORCID: https://orcid.org/0000-0001-7485-0583)
- Lara García-Delgado
- Alicia Hernanz‐Lobo (ORCID: https://orcid.org/0000-0002-9560-9104)
- Marius George Linguraru (ORCID: https://orcid.org/0000-0001-6175-8665)
Institutions
- Universidad Complutense de Madrid (ES)
- Children's National (US)
- Desmond Tutu HIV Foundation (ZA)
- George Washington University (US)
- University of Washington (US)
- Stellenbosch University (ZA)
- Instituto de Salud Carlos III (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Research Institute Hospital 12 de Octubre (ES)
- Departament de Salut (ES)
- Hospital Universitario 12 De Octubre (ES)
- Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES)
- Centro de Investigación Biomédica en Red (ES)
- Manhiça Health Research Centre (MZ)
- Hospital General de Catalunya (ES)
- HM Hospitales (ES)
- Sant Joan de Déu Research Foundation (ES)
- Hospital Materno-Infantil (ES)
- Barcelona Institute for Global Health (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- European Telecommunications Standards Institute (FR)
- Universitat de Barcelona (ES)
- Universidad Politécnica de Madrid (ES)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1038/s41467-025-64391-1
- Citations
- 4
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 5.58
Funders
- European Respiratory Society
- European Commission
- Universidad Politécnica de Madrid
- Ministerio de Ciencia e Innovación
- Horizon 2020 Framework Programme
- Instituto de Salud Carlos III
- European Regional Development Fund
- Agencia Estatal de Investigación
- European and Developing Countries Clinical Trials Partnership